Filing Details

Accession Number:
0001209191-20-054024
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-06 16:53:15
Reporting Period:
2020-10-05
Accepted Time:
2020-10-06 16:53:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1524472 Xylem Inc. XYL Pumps & Pumping Equipment (3561) 452080495
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1654800 David Flinton C/O Xylem Inc.
1 International Drive
Rye Brook NY 10573
Senior Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-05 6,448 $35.96 32,205 No 4 M Direct
Common Stock Disposition 2020-10-05 6,448 $86.05 25,757 No 4 S Direct
Common Stock Acquisiton 2020-10-05 12,472 $37.47 38,229 No 4 M Direct
Common Stock Disposition 2020-10-05 12,472 $86.05 25,757 No 4 S Direct
Common Stock Acquisiton 2020-10-05 11,737 $48.33 37,494 No 4 M Direct
Common Stock Disposition 2020-10-05 11,737 $86.05 25,757 No 4 S Direct
Common Stock Disposition 2020-10-05 2,729 $86.05 23,028 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Employee Stock Option (Right to Buy) Disposition 2020-10-05 6,448 $0.00 6,448 $35.96
Common Employee Stock Option (Right to Buy) Disposition 2020-10-05 12,472 $0.00 12,472 $37.47
Common Employee Stock Option (Right to Buy) Disposition 2020-10-05 11,737 $0.00 11,737 $48.33
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-02-24 No 4 M Direct
0 2026-02-24 No 4 M Direct
0 2027-02-21 No 4 M Direct
Footnotes
  1. These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan which was adopted on September 4, 2020
  2. This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,200 shares were executed at prices ranging from $85.04 to $86.03 per Share. 4,248 shares were executed at prices ranging from $86.05 to $86.52. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  3. This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,720 shares were executed at prices ranging from $84.92 to $85.88 per Share. 9,752 shares were executed at prices ranging from $85.925 to $86.45. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  4. This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,037 shares were executed at prices ranging from $85.05 to $86.04 per Share. 7,700 shares were executed at prices ranging from $86.05 to $86.52. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  5. These shares are sold pursuant to a 10b5-1 plan adopted by the reporting person on September 4, 2020
  6. This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,372 shares were executed at prices ranging from $85.39 to $86.36 per Share. 357 shares were executed at prices ranging from $86.39 to $86.46. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price
  7. These options are fully vested and exercisable as of February 24,2018.
  8. These options are fully vested and exercisable as of February 24,2019.
  9. These options are fully vested and exercisable as of February 21,2020.